Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2020
Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients with Chronic Lymphocytic Leukemia
Epistemonikos ID: def60cdaf5bcbcd3c3ccb211fb04e6d3a374da18
First added on: Jan 21, 2022